Clinical Trial Update: Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD) [Phase 1]

View source ↗

Summary

This document reports a Phase 1 pharmacokinetics and safety study of zuranolone in adolescent participants with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Zuranolone (zuranolone)

Snippet

Sponsor: Biogen | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED